✦ LIBER ✦

Ovarian Cancer: Advances in First-Line Treatment Strategies with a Particular Focus on Anti-Angiogenic Agents

✍ Scribed by Fiona J. Collinson, Jenny Seligmann, Timothy J. Perren

Book ID: 118819674
Publisher: Current Science Inc.
Year: 2012
Tongue: English
Weight: 200 KB
Volume: 14
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-012-0274-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An update on molecularly targeted therap

An update on molecularly targeted therapies in second- and third-line treatment in non-small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents

✍ Majem, M.; PallarÃ¨s, C. 📂 Article 📅 2013 🏛 Springer Milan 🌐 Spanish ⚖ 460 KB

NICE guidance on bevacizumab in combinat

NICE guidance on bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer

✍ Dyer, Matthew; Richardson, Joanna; Robertson, Janet; Adam, Jane 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 52 KB

First-Line Single Agent Treatment With G

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Phase II Study

✍ Niho, S. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 124 KB

Efficacy of gefitinib as a first-line si

Efficacy of gefitinib as a first-line single agent treatment in patients with advanced non-small cell lung cancer

✍ Yin, Yongmei; Geng, Yiting; Li, Xiaodong; Hu, Xiaoli; Chen, Xiaofeng; Li, Wei; S 📂 Article 📅 2009 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 490 KB

A phase II study of weekly carboplatin a

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer: A Multicentre Italian Trial in Ovarian cancer (MITO-5) study

✍ Sandro Pignata; Enrico Breda; Giovanni Scambia; Carmela Pisano; Vittorina Zagone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Interferon-gamma in combination with car

Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study

✍ C. MARTH; G.H. WINDBICHLER; H. HAUSMANINGER; E. PETRU; K. ESTERMANN; A. PELZER; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB